Roche announced a new Phase III Alzheimer’s disease prevention trial SKYLINE with gantenerumab, an investigational anti-amyloid antibody that is administered subcutaneously.
Roche intends to...
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced that it has established...
The Janssen Pharmaceutical Companies of Johnson & Johnson and its China-focused partner Legend Biotech Corp. developed a therapy to treat a type of white blood...
RUDN University scientists together with colleagues from Switzerland proved in a clinical trial the effectiveness of a new dosage form — amorphous solid dispersion....
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub.
The World Health Organization (WHO), the Republic of Korea and...
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will be the first African countries to receive the technology required to produce mRNA vaccines on...